However, in a recent, elegant work, in which newly diagnosed and treatment naïve ACRO patients were included, Olarescu et al. found that those patients with high visceral adipose tissue (VAT) presented lower GH levels, higher HOMA-IR, and worse glucose metabolism and lipid profile than patients with normal VAT without insulin resistance [48]. The gene discussed is GH1; the disease is Insulin resistance.